Hyperbaric Oxygen Therapy and Its Suitability as an Adjuvant for Treatment of Covid-19 Patients: A Review

Sameera Dawar (1) , Meena Jain (2)
(1) Department of Public Health Dentistry and Research and Innovation Catalyst, Manav Rachna Dental College, FDS, MRIIRS, Faridabad, Haryana, India, India ,
(2) Department of Public Health Dentistry and Research and Innovation Catalyst, Manav Rachna Dental College, FDS, MRIIRS, Faridabad, Haryana, India, India

Abstract

The outbreak of the SARS CoV2 'Coronavirus pandemic' is believed to have originated in Wuhan in 2019 as a zoonotic spread from bats to humans. It is a highly communicable infection-causing rapid human to human transmission of the virus by virtue of its infectious and pleomorphic nature. The virus has affected millions of people worldwide, with numbers still rising with each passing day. Depleting oxygen saturation levels is amongst the prime concerns in the majority of infected patients. Nasal prongs, face masks, mechanical ventilation and extracorporeal membrane (ECMO) are the commonly used modes of oxygen delivery in such patients. These methods though mostly successful, at times fail to restore the depleting oxygen levels to normal. Hyperbaric oxygen therapy (HBOT) involves the administration of 100% O2 in a special chamber whose pressure is maintained at a level greater than 1 ATP. The main purpose for raising the pressure within the chamber is that as the atmospheric pressure increases, the saturation levels of oxygen in the blood also increase, which eventually result in increased overall tissue oxygenation. This article provides a systematic and wholesome review on the basic principle of hyperbaric oxygen therapy, its effects on the body at a microscopic and macroscopic level, its various uses and its suitability as an adjuvant for the treatment of select COVID-19 infected patients.

Full text article

Generated from XML file

References

Abidia, A., Laden, G., Kuhan, G., Johnson, B. F., Wilkinson, A. R., Renwick, P. M., Masson, E. A., Mccollum, P. T. 2003. The role of hyperbaric oxygen theapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. European journal of vascular and endovascular surgery, 25(6):513–518.

Al-Waili, N. S., Butler, G. J., Beale, J., Abdullah, M. S., Finkelstein, M., Merrow, M., Rivera, R., Petrillo, R., Carrey, Z., Lee, B., Allen, M. 2006. Influences of hyperbaric oxygen on blood pressure, heart rate and blood glucose levels in patients with diabetes mellitus and hypertension. Archives of medical research, 37(8):991–997.

Balaji, S., Balaji, P. 2019. Textbook of Oral and Maxillofacial Surgery, 3rd edition. pages 556–563, India. Elsevier. ISBN: 9788131249291.

Barnes, R. C. 2006. Point: hyperbaric oxygen is beneficial for diabetic foot wounds. Clinical infectious diseases, 43(2):188–192.

Baroni, G., Porro, T., Faglia, E., Pizzi, G., Mastropasqua, A., Oriani, G., Pedesini, G., Favales, F. 1987. Hyperbaric oxygen in diabetic gangrene treatment. Diabetes care, 10(1):81–86.

Broussard, C. L. 2004. Hyperbaric oxygenation and wound healing. Journal of Vascular Nursing, 22(2):42–48.

Buboltz, J. B., Robins, M. 2017. Hyperbaric treatment of carbon monoxide toxicity. StatPearls. Updated on: 21 April 2021.

CDC 2021. Symptoms of Covid-19. Centers for Disease Control and Prevention, Accessed on: 22 May 2021.

Costanzo, L., Palumbo, F. P., Ardita, G., Antignani, P. L., Arosio, E., Failla, G. 2020. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia. Journal of Vascular Surgery: Venous and Lymphatic Disorders, 8(5):711–716.

Cronje, F. J. 1998. A review of the Marx protocols: prevention and management of osteoradionecrosis by combining surgery and hyperbaric oxygen therapy. SADJ: journal of the South African Dental Association= tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging, 53(10):469–471.

Dawar, S., Jain, M. 2021. Current Status of the Coronavirus Vaccination Development: A Review. Annals of the Romanian Society of Cell Biology, 25(6):16650–16662.

Gill, A. A., Bell, C. N. 2004. Hyperbaric oxygen: its uses, mechanisms of action and outcomes. Qjm, 97(7):385–395.

Gorenstein, S. A., Castellano, M. L., et al. 2020. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls. Undersea Hyperbaric Medical Society, 47(3):405–413.

Guo, D., Pan, S., Wang, M., Guo, Y. 2020. Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports. Undersea Hyperb Med, 47(2):181–187.

Halbach, J. L., Prieto, J. M., Wang, A. W., Hawisher, D., Cauvi, D. M., Reyes, T., Okerblom, J., Ramirez- Sanchez, I., Villarreal, F., Patel, H. H., Bickler, S. W. 2019. Early hyperbaric oxygen therapy improves survival in a model of severe sepsis. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 317(1):160–168.

Hammarlund, C., Sundberg, T. 1994. Hyperbaric oxygen reduced size of chronic leg ulcers: a randomized double-blind study. Plastic and reconstructive surgery, 93(4):829–833.

Heyboer-III, M., Sharma, D., Santiago, W., Mcculloch, N. 2017. Hyperbaric oxygen therapy: side effects defined and quantified. Advances in wound care, 6(6):210–224.

Johns Hopkins Medicine 2021. Complications of Hyperbaric Oxygen Treatment. Health, Accessed on: 21 July 2021.

Kindwall, E. P., Gottlieb, L. J., Larson, D. L. 1991. Hyperbaric oxygen therapy in plastic surgery: a review article. 88(5):898–908.

Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., Lessler, J. 2020. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals of internal medicine, 172(9):577–582.

Löndahl, M., Katzman, P., Nilsson, A., Hammarlund, C. 2010. Hyperbaric oxygen therapy facilitates the healing of chronic foot ulcers in patients with diabetes. Diabetes care, 33(5):998–1003.

Mader, J. T., Adams, K. R., Wallace, W. R., Calhoun, J. H. 1990. Hyperbaric oxygen as adjunctive therapy for osteomyelitis. Infectious disease clinics of North America, 4(3):433–440.

Marx, R. E., Feldmeier, J. J., Johnson, R. P. 2019. Hyperbaric oxygen is still needed in the management and prevention of mandibular necrosis: a response to Mr. Richard Clarke. Undersea and hyperbaric medicine: journal of the Undersea and Hyperbaric Medical Society, Inc, 46(4):399–408.

McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., Piantadosi, C. A. 2002. Nitric oxide in the human respiratory cycle. Nature medicine, 8(7):711–717.

McMonnies, C. W. 2015. Hyperbaric oxygen therapy and the possibility of ocular complications or contraindications. Clinical and Experimental Optometry, 98(2):122–125.

Memar, M. Y., Yekani, M., Alizadeh, N., Baghi, H. B. 2019. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomedicine and Pharmacotherapy, 109:440–447.

Nichols, C. W., Lambertsen, C. J. 1969. Effects of high oxygen pressures on the eye. New England Journal of Medicine, 281(1):25–30.

Perng, W. C., Wu, C. P., Chu, S. J., Kang, B. H., Huang, K. L. 2004. Effect of hyperbaric oxygen on endotoxin-induced lung injury in rats. Shock, 21(4):370–375.

Perricone, C., Bartoloni, E., Bursi, R., Cafaro, G., Guidelli, G. M., Shoenfeld, Y., Gerli, R. 2020. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunologic research, 68(4):213–224.

Rao, G. U. 2008. Current concepts in the intensive care management of neurosurgical patients. Indian Journal of Anaesthesia, 52(5):494.

Sahin, S. H., Kanter, M., Ayvaz, S., Colak, A., Aksu, B., Guzel, A., Basaran, U. N., Erboga, M., Ozcan, A. 2011. The effect of hyperbaric oxygen treatment on aspiration pneumonia. Journal of molecular histology, 42(4):301–310.

Salmen, M., Hendriksen, S., Gorlin, J., LeClaire, M., Prekker, M. E. 2017. Oxygen delivery during severe anemia when blood transfusion is refused on religious grounds. Annals of the American Thoracic Society, 14(7):1216–1220.

Senniappan, K., Jeyabalan, S., Rangappa, P., Kanchi, M. 2020. Hyperbaric oxygen therapy: Can it be a novel supportive therapy in COVID-19? Indian Journal of Anaesthesia, 64(10):835–841.

Shah, J. 2010. Hyperbaric oxygen therapy. The Journal of the American College of Certified Wound Specialists, 2(1):9–13.

Shang, W., Yang, Y., Rao, Y., Rao, X. 2020. The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines. npj Vaccines, 5(1):1–3.

Sivapathasundharam, B. 2009. Shafer’s Textbook of Oral Pathology, 6th edition. pages 493–499, India. Elsevier. ISBN: 9788131215708.

Skevas, T., Baumann, I., Bruckner, T., Clifton, N., Plinkert, P. K., Klingmann, C. 2012. Medical and surgical treatment in divers with chronic rhinosinusitis and paranasal sinus barotrauma. European Archives of Oto-Rhino-Laryngology, 269(3):853–860.

Stoetzer, M., Kuehlhorn, C., Ruecker, M., Ziebolz, D., Gellrich, N. C., See, C. 2012. Pathophysiology of barodontalgia: a case report and review of the literature. Case reports in dentistry.

Strauss, M. B. 2005. Hyperbaric oxygen as an intervention for managing wound hypoxia: its role and usefulness in diabetic foot wounds. Foot and Ankle International, 26(1):15–18.

Thibodeaux, K., Speyrer, M., Raza, A., Yaakov, R., Serena, T. E. 2020. Hyperbaric oxygen therapy in preventing mechanical ventilation in COVID-19 patients: a retrospective case series. Journal of wound care, 29(Sup 5a):4–8.

Williams, T. M., Davis, R. W. 2020. Physiological resilience in diving mammals: insights on hypoxia protection using the Krogh principle to understand COVID-19 symptoms. Comparative Biochemistry and Physiology Part A: Molecular and Integrative Physiology, 253:110849.

Wool, G. D., Miller, J. L. 2021. The impact of COVID-19 disease on platelets and coagulation. Pathobiology, 88(1):15–27.

Xu, Z., Shi, L., et al. 2020. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet respiratory medicine, 8(4):420–422.

Yanagawa, Y. 2021. Current status of hyperbaric oxygen therapy for COVID-19. Acute Medicine and Surgery, 8(1):e678.

Yang, Z., Hu, J., Qu, Y., Sun, F., Leng, X., Li, H., Zhan, S. 2015. Interventions for treating gas gangrene. Cochrane Database of Systematic Reviews, (12):CD010577.

Yuki, K., Fujiogi, M., Koutsogiannaki, S. 2020. COVID-19 pathophysiology: A review. Clinical immunology, 215:108427.

Zamboni, W. A., Oriani, G., Marroni, A., Wattel, F. 1996. Applications of hyperbaric oxygen therapy in plastic surgery. In Handbook on Hyperbaric Medicine, pages 443–507, New York. Springer.

Zeng, Y., Cai, Z., Xianyu, Y., Yang, B. X., Song, T., Yan, Q. 2020. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series. Critical Care, 24(1):1–3.

Zhong, X., Tao, X., Tang, Y., Chen, R. 2020. The outcomes of hyperbaric oxygen therapy to retrieve hypoxemia of severe novel coronavirus pneumonia: a first case report. In Zhonghua Hanghai Yixue yu Gaoqiya Yixue Zazhi.

Authors

Sameera Dawar
Meena Jain
drmeenabansal@gmail.com (Primary Contact)
Sameera Dawar, & Meena Jain. (2021). Hyperbaric Oxygen Therapy and Its Suitability as an Adjuvant for Treatment of Covid-19 Patients: A Review. International Journal of Research in Pharmaceutical Sciences, 12(4), 2548–2556. Retrieved from https://ijrps.com/home/article/view/491

Article Details

No Related Submission Found